For travellers on hormone replacement therapy (HRT), maintaining continuity through extended trips matters for both physical and mental wellbeing. Specific considerations: Bring sufficient supply — calculate based on trip length + 2 weeks reserve; Carry prescriptions — translated to English if travelling to non-English destinations; Customs declarations — some countries require declaration of prescription medications; Refill access — research destination pharmacy access in case of trip extension or supply loss.
Time-zone shifts and dosing
For daily medications, time-zone shifts can disrupt dosing schedules. Estrogen daily oral — shift gradually (1-2 hours/day) toward destination time-zone. Estrogen patches — change schedule may need to shift; not time-of-day-sensitive. Testosterone injection — weekly schedule allows easy time-zone adjustment. Spironolactone — twice-daily; shift gradually. Specific dose timings should be discussed with prescriber before extended trips.
Destination-specific HRT access
Some destinations make HRT continuation easier than others: Argentina, Brazil, Mexico, Thailand — HRT pharmacy-accessible OTC or with simple prescription; quality reliable. EU markets — prescription required but accessible; quality reliable. UK, US — prescription required; specialty clinic access. Most Muslim-majority countries, Russia post-2023, parts of Africa — restricted or unavailable; bring supply. Saudi Arabia, UAE — restricted; some medications confiscated at customs.
HRT drug interactions
HRT medications interact with various substances and other medications. Estrogen + smoking — increased blood-clot risk; particularly relevant for long-haul flights; consider blood-clot prevention. Estrogen + alcohol — minimal direct interaction but compound liver stress. Spironolactone + dehydration — electrolyte risk; matters in hot destinations. Testosterone + ED medications — generally compatible; check specifics. HRT + chemsex drugs — limited research but interaction risk; consult before use.
PrEP and HRT
For trans clients on both HRT and PrEP, the interaction is well-studied and generally manageable. Tenofovir + estrogen — no clinically significant interaction. Tenofovir + testosterone — no clinically significant interaction. Concern points: kidney function monitoring (relevant for tenofovir generally); some prescribers prefer tenofovir alafenamide (TAF) over the standard TDF for trans patients. Discuss with prescriber.
Aesthetic and physical considerations
For trans clients in adult-tourism contexts, HRT effects matter beyond medical: Skin sensitivity changes with HRT and affects activity choices; Genital response changes with HRT and affects what activities are physically possible; Body fat distribution changes affect appearance and self-image. Communicate openly with providers about what's comfortable and what's not.
Practical recommendations
(1) Carry adequate HRT supply with prescriptions; (2) Plan time-zone dose adjustments; (3) Verify destination access before trip; (4) Don't skip doses during travel disruption; (5) Note interactions with other medications and substances; (6) Maintain prescriber contact during extended trips; (7) Don't experiment with new medications during travel.
